PULMATRIX, INC. Increase (Decrease) in Prepaid Expense
PULMATRIX, INC. (PULM) reported Increase (Decrease) in Prepaid Expense of $163.00 thousand for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2015-06-10
- PULMATRIX, INC. increase (decrease) in prepaid expense for the quarter ending 2015-03-31 was -$33.00K.
- PULMATRIX, INC. increase (decrease) in prepaid expense for the quarter ending 2014-12-31 was -$90.00K, a 300.00% decline year-over-year.
- PULMATRIX, INC. increase (decrease) in prepaid expense for the quarter ending 2014-09-30 was -$88.00K, a 184.62% decline year-over-year.
- PULMATRIX, INC. increase (decrease) in prepaid expense for the quarter ending 2014-06-30 was $374.00K, a 277.78% increase year-over-year.
- PULMATRIX, INC. increase (decrease) in prepaid expense for fiscal 2015 was $163.00K.
- PULMATRIX, INC. increase (decrease) in prepaid expense for fiscal 2014 was -$1.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2015-03-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | -$123.00K derived: sum of 2 quarters · filed 2015-06-10 | -$211.00K derived: sum of 3 quarters · filed 2015-06-10 | $163.00K 10-K · filed 2015-06-10 |
| 2014-12-31 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | -$178.00K derived: sum of 2 quarters · filed 2015-02-13 | $196.00K 10-Q · filed 2015-02-13 | -$53.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-09-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $286.00K 10-Q · filed 2014-11-13 | $37.00K derived: sum of 3 quarters · filed 2015-06-10 | $82.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-06-30 | $374.00K 10-Q · filed 2014-08-14 | $125.00K derived: sum of 2 quarters · filed 2015-06-10 | $170.00K derived: sum of 3 quarters · filed 2015-06-10 | $274.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-03-31 | -$249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | -$204.00K derived: sum of 2 quarters · filed 2015-06-10 | -$100.00K derived: sum of 3 quarters · filed 2015-06-10 | -$1.00K 10-K · filed 2015-06-10 |
| 2013-12-31 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $149.00K derived: sum of 2 quarters · filed 2015-02-13 | $248.00K 10-Q · filed 2015-02-13 | |
| 2013-09-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $203.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $99.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |